Skip to main content
Support Quality Journalism.
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just
$1.99
per week
for first 24 weeks
Enjoy unlimited digital access
START TODAY
Get full access to globeandmail.com
Just $1.99 per week
for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //
The Globe and Mail
Member Benefits
Subscribe
Subscribe
Register
Log in
My account
Following
Bookmarks
Reading history
Newsletters
Subscriptions
Settings
Help
My account
Following
Bookmarks
Reading history
Newsletters
Subscriptions
Settings
Help
AdChoices
Canada
World
Business
Investing
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Watchlist
Search
Search
Quick links
Horoscopes
Puzzles
Member Benefits
Newsletters
Globe Shop
Investigations
Death Notices (Legacy.com)
Reader services
Subscribe
Following
Subscriptions
Settings
Customer Help
Contact us
Log in
Log out
Johnson & Johnson
Follow
Latest
u.s. business
Johnson & Johnson confident of March rollout for its COVID-19 vaccine, still aims for 1 billion doses in 2021
January 13
Updated
u.s. business
Johnson & Johnson ordered to pay $120-million damages in New York baby powder case
November 20
Updated
world
Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization
November 18
Updated
u.s. business
Johnson & Johnson fails to overturn $2.12-billion baby powder verdict, plans U.S. Supreme Court appeal
November 3
Updated
u.s. business
McKesson says cost of opioid settlements could reach $21-billion
November 3
Updated
u.s. business
Johnson & Johnson hikes profit forecast, but pause in COVID-19 vaccine trial weighs on shares
October 13
Updated
More Stories Below Advertisement
market news
The close: Stocks fall amid fresh worries over COVID-19 cases, vaccines
October 13
Updated
international business
Johnson & Johnson COVID-19 vaccine trial paused as participant’s illness is evaluated
October 12
Updated
u.s. business
Johnson & Johnson to pay about US$100-million to settle more than 1,000 talc lawsuits: report
October 5
Updated
u.s. business
Johnson & Johnson kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers
September 23
Updated
u.s. business
Johnson & Johnson facing insurance fraud charges in New York over opioid claims
September 17
Updated
international business
Johnson & Johnson COVID-19 vaccine trial saw some volunteers quit after AstraZeneca scare
September 15
Updated
politics
Economists question Ottawa’s refusal to release COVID-19 vaccine cost estimates
September 2
Updated
world
Johnson & Johnson to begin mid-stage coronavirus vaccine trials in three European countries
August 28
Updated
u.s. business
Johnson & Johnson to test potential coronavirus vaccine in up to 60,000 volunteers
August 20
Updated
u.s. business
Johnson & Johnson buying Momenta Pharmaceuticals for around $6.5-billion
August 19
Updated
More Stories Below Advertisement
u.s. business
U.S. states reportedly seeking $26.4-billion from drug firms in opioid litigation
August 18
Updated
u.s. business
J&J starts human safety trial for its COVID-19 vaccine candidate
July 30
Updated
international business
J&J working on COVID-19 vaccine deals with Japan and Gates Foundation
July 16
Updated
u.s. business
Johnson & Johnson raises forecast after quarterly profit beats estimates
July 16
Updated
u.s. business
Missouri court upholds verdict in Johnson & Johnson talc case but reduces damages to $2.1-billion
June 23
Updated
world
European Commission in advanced talks with Johnson & Johnson on COVID-19 vaccine deal, sources say
June 18
Updated
u.s. business
Johnson & Johnson moves up start of coronavirus vaccine human trials to July
June 10
Updated
u.s. business
Chanel, Revlon, L’Oreal pivoting away from talc in some products
June 9
Updated
international business
Johnson & Johnson to stop selling talc-based baby powder in Canada and U.S.
May 19
Updated
u.s. business
U.S. judge rules talc lawsuits against J&J can proceed, testimony limited
April 27
Updated
stars and dogs
The Globe’s stars and dogs for the week
April 17
Updated
canada
Evening Update: Ottawa, provinces in talks to reopen economy in stages; Trudeau and Scheer face criticism over travel
April 14
Updated
u.s. business
Johnson & Johnson sees recovery in coronavirus-hit medical devices unit at end of year
April 14
Updated
u.s. business
Johnson & Johnson aims to begin testing of coronavirus vaccine by September, plans to manufacture 1 billion doses
March 30
Updated
u.s. business
Johnson & Johnson ramps up Tylenol production as demand surges
March 13
Updated
technology
Apple, J&J to study if Apple Watch can help reduce stroke risk
February 25
Updated
View More Stories
To view this site properly, enable cookies in your browser. Read our
privacy policy
to learn more.
How to enable cookies